Boehringer lngelheim Therapeutics Gmbh – FDA Inspection, Sep 26, 2018

Record Details

This FDA Inspection record concerns Boehringer lngelheim Therapeutics Gmbh, with an inspection on September 26, 2018, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Boehringer lngelheim Therapeutics Gmbh
Inspection Date: September 26, 2018
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Brian D. Nicholson (FDA Associated Person)

View Company Profile

ID · daae53dd-a5bc-451f-914f-f5badf765783

Inspection Facts

Inspection number: 1070155
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer lngelheim Therapeutics Gmbh

FDA Inspection

Boehringer lngelheim Therapeutics GmbhSeptember 26, 2018

Boehringer lngelheim Therapeutics Gmbh – FDA Inspection, Sep 26, 2018

Record Details

This FDA Inspection record concerns Boehringer lngelheim Therapeutics Gmbh, with an inspection on September 26, 2018, issued by the Office of Inspections and Investigations, covering human drugs.